Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in elective total knee replacement surgery
2011-000693-57Phase 2Completed
- Sponsor
- HÃ¥kan Ledin (investigator initiated trial)
- Start
- Oct 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Denosumab with Placebo (2 arms). Primary endpoint: Maximal total point motion at 1 year. Started Oct 2011; status: completed.
02
Drugs
denosumab
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-000693-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000693-57.